IMNN · Imunon, Inc.
$1.53
+0.01 (+0.33%)
At close · Jul 27
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Such conditions raise substantial doubts about the Company's ability to continue as a going concern. Based on the above, management has determined there is substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed May 12, 2026
Market Cap
$6.35M
Shares
4.20M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$500K
0%
FY2023
Net Income
-$14.5M
+22.2%
FY2025
Operating Margin
-4206.09%
+778.2pp
FY2023
Diluted EPS
-$6.83
+67.7%
FY2025
Operating Cash Flow
-$13.9M
+26.3%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | $500K | $500K | $500K | $500K | $500K | $500K | — | — | $125K | — | — | — | — | |
| $7.95M | $7.78M | $11.64M | $11.29M | $11.73M | $10.62M | $11.34M | $13.07M | $11.87M | $13.08M | $14.62M | $14.66M | $14.97M | $9.36M | $15.77M | $19.86M | |
| $6.86M | $6.87M | $7.49M | $9.74M | $13.69M | $10.89M | $7.64M | $8M | $9.7M | $5.89M | $6.53M | $6.69M | $8.86M | $6.55M | $6.37M | $5.15M | |
| — | — | — | — | — | — | — | — | $227.32K | $5625 | $5625 | $7500 | $7500 | $7500 | $7500 | $7500 | |
| — | — | $240K | $248K | $731.63K | $702.92K | $741.52K | $721.67K | $356.86K | $553.01K | $1.02M | $424.97K | $369.33K | $339.23K | $281.49K | $169.36K | |
| $14.81M | $14.65M | $19.13M | $21.03M | $25.42M | $21.51M | $18.99M | $21.07M | $21.57M | $18.97M | $21.15M | $21.35M | $25.22M | $15.91M | $22.14M | $25.02M | |
| -$14.81M | -$14.65M | -$19.13M | -$21.03M | -$24.92M | -$21.01M | -$18.49M | -$20.57M | -$21.07M | -$18.47M | -$20.65M | -$20.85M | -$24.72M | -$15.41M | -$22.14M | -$23.02M | |
| — | — | — | -4206.09% | -4984.31% | -4201.44% | -3697.28% | -4113.09% | -4213.01% | — | — | -16677.43% | — | — | — | — | |
| — | — | -$18.89M | -$20.78M | -$24.19M | -$20.3M | -$17.74M | -$19.84M | -$20.71M | -$17.92M | -$19.63M | -$20.42M | -$24.35M | -$15.07M | -$21.86M | -$22.85M | |
| — | — | $197.08K | $197.08K | $5.03M | $569.88K | — | — | — | — | — | — | — | — | $359.41K | — | |
| -$65.69K | — | — | — | — | — | — | — | — | — | — | — | — | -$12.74K | — | $174.06K | |
| — | $155.67K | $512.2K | $235.07K | -$12.54M | -$1.15M | -$4.84M | $1.9M | -$1.24M | -$1.93M | -$1.4M | -$1.61M | -$779.08K | $7.16M | -$4.43M | -$203.91K | |
| — | $61.98K | $61.98K | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | $14.5M | -$18.62M | -$20.8M | -$37.47M | -$22.15M | -$23.33M | -$18.67M | -$22.3M | — | — | — | — | — | — | -$23.22M | |
| — | — | -$1.28M | -$1.28M | -$1.57M | -$1.38M | -$1.85M | -$1.82M | -$10.42M | — | — | — | — | — | — | $0 | |
| -$14.64M | -$14.5M | -$18.62M | -$19.51M | -$35.9M | -$20.77M | -$21.48M | -$16.85M | -$11.88M | -$20.4M | -$22.05M | -$22.46M | -$25.49M | -$8.25M | -$26.57M | -$23.22M | |
| — | — | — | -3903% | -7179.65% | -4153.85% | -4296.71% | -3370.31% | -2376.67% | — | — | -17968.87% | — | — | — | — | |
| — | — | — | — | — | — | — | — | -$11.88M | -$20.75M | -$22.05M | -$22.46M | -$25.49M | -$12.85M | — | — | |
| -$15.75M | — | -$18.62M | -$19.48M | -$35.87M | -$20.76M | -$21.53M | -$16.84M | -$11.84M | -$20.41M | -$22.05M | -$22.45M | -$25.47M | -$8.17M | -$26.42M | -$23.48M | |
| USD/shares | — | -$6.83 | -$21.13 | -$28.17 | -$65.61 | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$6.83 | -$21.13 | -$28.17 | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 2.12M | 882.29K | 693.47K | 547.63K | 416.07K | 163.36K | 111.59K | 89.87K | 38.98K | 132.67K | 111.49K | 94.41K | 69.21K | 177.81K | — |
| shares | — | 2.12M | 882.29K | 693.47K | — | 416.07K | 163.36K | 111.59K | 89.87K | 38.98K | 132.67K | 111.49K | 94.41K | 69.21K | 177.81K | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—
Peer median 0.04×
Peer medians compare against the 168 similar-size Biotechnology companies (of 521 listed).